Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017

BackgroundWith the advent of tyrosine kinase inhibitors (TKIs), the prognosis of chronic myeloid leukemia (CML) seems to have dramatically improved over the last two decades. Accurate information of the global burden of CML is critical for direct health policy and healthcare resource allocation in t...

Full description

Bibliographic Details
Main Authors: Qingqing Lin, Liping Mao, Li Shao, Li Zhu, Qingmei Han, Honghu Zhu, Jie Jin, Liangshun You
Format: Article
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Oncology
Online Access: